YYZ builds innovative technology platforms to enable new insights in modern medicine, with breakthroughs in the ultra-sensitive discovery & measurement of biomolecules. Supported by over 20 years of published research and backed by two visionary family offices, YYZ’s technology suite is powered by: 1) DPiPSA™ for Discovery (Database-Driven Proteome Intact Partition Statistical Analysis) - Unbiased & statistically rigorous bioinformatics for next-generation discovery & stratification. 2) ELiMSA™ for Measurement (Enzyme Linked Mass Spectrometric Assay) - Ultra-sensitive & quantitative assay technology with extensive life science applications.